stella
beta
Validation of DNA Methylation Markers for Universal and Site-specific Guided Cancer Detection, VANGUARD Study — Stella
Home
/
Hematopoietic and Lymphatic System Neoplasm
/
Validation of DNA Methylation Markers for Universal and Site-specific Guided Cancer Detection, VANGUARD Study
View on ClinicalTrials.gov
Recruiting
Back to Hematopoietic and Lymphatic System Neoplasm trials
Validation of DNA Methylation Markers for Universal and Site-specific Guided Cancer Detection, VANGUARD Study
Trial locations
(1 site)
United States
Mayo Clinic in Rochester, Rochester, Minnesota